期刊文献+

肿瘤家族史与胃癌患者临床病理特征关系的研究 被引量:1

Family history of cancer associated with gastric cancer clinicopathological features
下载PDF
导出
摘要 目的:探讨恶性肿瘤家族史(familial history of malignant neoplasm,MN-FH)对胃癌贡献比例及与临床病理特征之间的关系。方法:回顾我院2010年1月-2014年12月间收治的资料齐全的310例胃癌患者的临床病理资料,以有无肿瘤家族史分组,利用SPSS软件统计分析组间临床病理特征关系。结果:96例(31.0%)胃癌患者具有肿瘤家族史,其一级和二级亲属中共有64例(66.7%)具有消化道相关肿瘤,包括食管癌(19.8%)、胃癌(24.0%)、肝癌(6.3%)和结直肠癌(16.7%)。泌尿系肿瘤占12.5%,其他(包括甲状腺癌、乳腺癌、喉癌等)占20.8%。相关性分析显示有无肿瘤家族史在性别及肿瘤发生部位均没有差异(P>0.05)。病理分型显示有MN-FH的胃癌患者以低分化、未分化多见,占60.4%(58/96),无MN-FH占12.6%(27/214),两组相比,P<0.05。而在高、中分化腺癌类型上则相反,有MN-FH胃癌组占39.6%,无MN-FH胃癌组占87.3%,P<0.05。胃癌临床分期显示有MN-FH多以Ⅲ、Ⅳ期为主(73.0%),无MN-FH组以Ⅱ期为主(57.9%),两组相比,P<0.05,具有显著性差异。结论:我院超过1/3的胃癌患者具有阳性MN-FH。其中最常见的MN-FH是消化道肿瘤。MN-FH胃癌具有分化程度低,病理特征恶性程度高特点。对于有家族史人群定期体检非常重要,早诊和早治是提高生存率的关键。 Objective: To investigate the clinicopathological characteristics and familial history of malignant neoplasm( MN-FH) of gastric cancer patients. Methods: The clinical data of 310 cancer cases in our hospital during January 2010 to December 2014 were analyzed retrospectively. Results: 96 cases( 31. 0%) patients of gastric cancer had family history of cancer. Of the primary and secondary relatives,64 cases( 66. 7%) had digestive tract tumors,including esophageal cancer( 19. 8%),gastric cancer( 24. 0%),liver( 6. 3%) and colorectal cancer( 16. 7%). Urinary system tumor accounted for 12. 5%,other( including thyroid cancer,breast cancer,laryngeal cancer,etc.) accounted for 20. 8%. The correlation analysis showed that there was no difference between MN-FH and sex,the location of tumor( P 0. 05). The pathological typing showed that gastric cancer patients with MN-FH were mainly low differentiation and not differentiation,accounting for 60. 4%( 58 /96),no MN-FH accounted for 12. 6%( 27 /214),compared with the two group,P 0. 05. While in the high and medium differentiated adenocarcinoma types,there was39. 6% in MN-FH gastric cancer patients,was 7. 3% in no MN-FH gastric cancer group,P 0. 05. The clinical staging of gastric cancer showed that gastric cancer patients with MN-FH were mainly IV stage( 73. 0%),and no MN-FH group( 57. 9%),P 0. 05. Conclusion: Over 1 /3 in our hospital patients of gastric cancer had a positive MN-FH. The most common forms is gastrointestinal cancer. MN-FH gastric cancer has the features of low differentiation degree and high pathological features of malignant degree. It is important to early diagnoze and treat patients of gastric cancer with positive MN-FH.
出处 《现代肿瘤医学》 CAS 2015年第22期3273-3275,共3页 Journal of Modern Oncology
基金 国家自然科学基金(编号:81402583) 陕西省自然科学基金(编号:2014JQ4165) 西安交通大学校基金(编号:xjj2014077)
关键词 胃癌 恶性肿瘤家族史 临床病理特征 gastric cancer familial history of malignant neoplasm(MN-FH) clinicopathological characteristics
  • 相关文献

参考文献3

二级参考文献54

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA CancerJ Clin, 2011, 61 (2):69-90.
  • 2Philippar U, Roussos ET, Oser M, et al. A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis [J]. Dev Cell, 2008, 15(6):813-828.
  • 3Gurzu S, Jung I, Prantner I, et al. The expression of cytoskeleton regulatory protein Mena in colorectal lesions[J]. Rom j Morphol Embryol, 2008, 49(3):345-349.
  • 4Gurzu S, Jung I, Prantner I, et al. The immunohistochemical as- pects of protein Mena in cervical lesions[J]. Rom J Morphol Em- bryo1, 2009, 50(2):213-216.
  • 5Bosman FI', Carneiro F, Hruban R, et al. WHO Classification of Tumours of the Digestive System[M]. 4th ed. IARC: Lyon, 2010, 45-58.
  • 6Di Modugno F, Bronzi G, Scanlan MJ, et al. Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and GD8+ T-cell immune response[J]. IntJ Cancer, 2004, 109(6):909-918.
  • 7ScottJA, Shewan AM, den Elzen NR, et al. Ena/VASP proteins can regulate distinct modes of actin organization at cadherin-adhesive contacts[J]. Mol Biol Cell, 2006, 17(3) :1085-1095.
  • 8Di Modugno F, Mottolese M, Di Benedetto A, et al. The cytoskele- ton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal recep- tor-negative minors[J]. Clin Cancer Res, 2006, 12(5):1470-1478.
  • 9Pino MS, Balsamo M, Di Modugno F, et al. Human Mena+lla iso- form serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines[J]. Clin Cancer Res, 2008, 14(15):4943-4950.
  • 10Di Modugno F, Iapicca P, Boudreau A, et al. Splicing program of human MENA produces a previously undescribed isoform associat- ed with invasive, mesenchymal-like breast tumors[J]. Proc Nat1 Acad Sd U S A, 2012, 109(47):19280-19285.

共引文献23

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部